TradeWorx’s Ironwood Pharmaceuticals IRWD Stock Holding History

TradeWorx’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-20,044	Closed	-$257K	–	301
2014 Q2	$257K	Buy	+20,044	New	+$218K	0.21%	199

Other funds holding IRWD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

TradeWorx's IRWD Position: Q3 2014 in Review

TradeWorx sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2014, closing a stake of 20,044 shares — an estimated $257K sold.

TradeWorx first reported a position in IRWD in Q2 2014 and held it in 1 quarter. The position peaked at $257K in Q2 2014. 140 funds tracked by Wall St. Rank hold IRWD as of Q3 2014.

TradeWorx reported no remaining Ironwood Pharmaceuticals position as of Q3 2014 after selling out during the quarter.
TradeWorx sold 20,044 Ironwood Pharmaceuticals shares in Q3 2014, an estimated $257K.
TradeWorx first reported a position in Ironwood Pharmaceuticals in Q2 2014 and held it in 1 quarter.
TradeWorx's Ironwood Pharmaceuticals position peaked at $257K in Q2 2014.
140 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2014.

Based on TradeWorx's 13F filing for Q3 2014, filed 1 Oct 2014.